Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Bibliografske podrobnosti
Main Authors:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Format:	Conference item
Jezik:	English
Izdano:	Cell Press 2021

Podobne knjige/članki

Development of protocols for mouse GLP-toxicology studies
od: Sinadinos, A, et al.
Izdano: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
od: Sinadinos, A, et al.
Izdano: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
od: Sergijenko, A, et al.
Izdano: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
od: Sergijenko, A, et al.
Izdano: (2020)

Gene therapy for respiratory diseases; progress and a changing context
od: Alton, EWFW, et al.
Izdano: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
od: Balázs Bender, et al.
Izdano: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
od: Tan, T, et al.
Izdano: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
od: Helena Lund-Palau, et al.
Izdano: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
od: Tan, TK, et al.
Izdano: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
od: Gelinas, J, et al.
Izdano: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
od: Gélinas, J, et al.
Izdano: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
od: Conway, CC, et al.
Izdano: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
od: Sinadinos, A, et al.
Izdano: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
od: Ashworth, R, et al.
Izdano: (2018)

Lentiviral Vector Bioprocessing
od: Christopher Perry, et al.
Izdano: (2021-02-01)

Production of lentiviral vectors
od: Otto-Wilhelm Merten, et al.
Izdano: (2016-01-01)

Advances of Lentiviral Vectors
od: Fanrong MENG, et al.
Izdano: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
od: Munday, R, et al.
Izdano: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
od: Munday, R, et al.
Izdano: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
od: Antepowicz, A, et al.
Izdano: (2021)

The very stable lentiviral vector
od: Gwendolyn K. Binder, et al.
Izdano: (2024-03-01)

Special Issue “Lentiviral Vectors”
od: Yasuhiro Takeuchi
Izdano: (2022-07-01)

The Inside Out of Lentiviral Vectors
od: Stéphanie Durand, et al.
Izdano: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
od: Agata Antepowicz, et al.
Izdano: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
od: Griesenbach, U, et al.
Izdano: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
od: Hyde, S, et al.
Izdano: (2016)

Lentiviral Vectors for Ocular Gene Therapy
od: Yvan Arsenijevic, et al.
Izdano: (2022-07-01)

Comparison of lentiviral vector titration methods
od: Debyser Zeger, et al.
Izdano: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
od: Logan Y. Brown, et al.
Izdano: (2020-12-01)

Rev-dependent lentiviral expression vector
od: Beddall Margaret H, et al.
Izdano: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
od: Yáñez-Muñoz, R, et al.
Izdano: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
od: Inès Dufait, et al.
Izdano: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
od: Massimo Conese, et al.
Izdano: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
od: Patrick L Sinn, et al.
Izdano: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
od: Munday, RJ, et al.
Izdano: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
od: Munday, RJ, et al.
Izdano: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
od: Griesenbach, D, et al.
Izdano: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
od: Alton, E, et al.
Izdano: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
od: Alton, E, et al.
Izdano: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
od: Munday, RJ, et al.
Izdano: (2022)